Question:
You are tasked with answering the user's question using the provided context, which includes financial statements (Income Statements, Balance Sheets, and Cash Flow Statements) and financial news articles in multiple languages (English, Chinese, Japanese, Spanish, and Greek). Please provide a detailed and well-supported answer based on the information available. Limit your response to 100 words or fewer. If you cannot answer the question or if no relevant evidence is found, write “None”.

Answer Format:
Answer: {Answer by summarizing the financial news.}
Financial Statements Evidence: {Verify your answer using quote(s) from the financial statements (include original amounts if relevant). Write “None” if no statement evidence is available.}
Context:
Financial Statements:
| Column 1                                                                      | Column 2              | Column 3   | Column 4          | Column 5   | Column 6   | Column 7   | Column 8   | Column 9   | Column 10   | Column 11   | Column 12   |
|:------------------------------------------------------------------------------|:----------------------|:-----------|:------------------|:-----------|:-----------|:-----------|:-----------|:-----------|:------------|:------------|:------------|
|                                                                               |                       |            |                   |            |            |            |            |            |             |             |             |
|                                                                               | September 30, 2024    |            | December 31, 2023 |            |            |            |            |            |             |             |             |
|                                                                               | (Dollars in millions) |            |                   |            |            |            |            |            |             |             |             |
| ASSETS                                                                        |                       |            |                   |            |            |            |            |            |             |             |             |
| Current assets                                                                |                       |            |                   |            |            |            |            |            |             |             |             |
| Cash and cash equivalents                                                     | $                     | 10,644     |                   |            | $          | 7,925      |            |            |             |             |             |
| Short-term investments                                                        | 275                   |            |                   | 170        |            |            |            |            |             |             |             |
| Accounts receivable, less allowances of $319and $323, respectively            | 7,884                 |            |                   | 7,530      |            |            |            |            |             |             |             |
| Inventories                                                                   | 6,338                 |            |                   | 6,178      |            |            |            |            |             |             |             |
| Assets held for sale                                                          | 1,518                 |            |                   | —          |            |            |            |            |             |             |             |
| Other current assets                                                          | 1,505                 |            |                   | 1,699      |            |            |            |            |             |             |             |
| Total current assets                                                          | 28,164                |            |                   | 23,502     |            |            |            |            |             |             |             |
| Investments and long-term receivables                                         | 1,463                 |            |                   | 939        |            |            |            |            |             |             |             |
| Property, plant and equipment—net                                             | 5,822                 |            |                   | 5,660      |            |            |            |            |             |             |             |
| Goodwill                                                                      | 21,270                |            |                   | 18,049     |            |            |            |            |             |             |             |
| Other intangible assets—net                                                   | 5,749                 |            |                   | 3,231      |            |            |            |            |             |             |             |
| Insurance recoveries for asbestos-related liabilities                         | 160                   |            |                   | 170        |            |            |            |            |             |             |             |
| Deferred income taxes                                                         | 374                   |            |                   | 392        |            |            |            |            |             |             |             |
| Other assets                                                                  | 10,490                |            |                   | 9,582      |            |            |            |            |             |             |             |
| Total assets                                                                  | $                     | 73,492     |                   |            | $          | 61,525     |            |            |             |             |             |
| LIABILITIES                                                                   |                       |            |                   |            |            |            |            |            |             |             |             |
| Current liabilities                                                           |                       |            |                   |            |            |            |            |            |             |             |             |
| Accounts payable                                                              | $                     | 6,640      |                   |            | $          | 6,849      |            |            |             |             |             |
| Commercial paper and other short-term borrowings                              | 3,135                 |            |                   | 2,085      |            |            |            |            |             |             |             |
| Current maturities of long-term debt                                          | 1,760                 |            |                   | 1,796      |            |            |            |            |             |             |             |
| Accrued liabilities                                                           | 7,566                 |            |                   | 7,809      |            |            |            |            |             |             |             |
| Liabilities held for sale                                                     | 433                   |            |                   | —          |            |            |            |            |             |             |             |
| Total current liabilities                                                     | 19,534                |            |                   | 18,539     |            |            |            |            |             |             |             |
| Long-term debt                                                                | 25,934                |            |                   | 16,562     |            |            |            |            |             |             |             |
| Deferred income taxes                                                         | 2,077                 |            |                   | 2,094      |            |            |            |            |             |             |             |
| Postretirement benefit obligations other than pensions                        | 122                   |            |                   | 134        |            |            |            |            |             |             |             |
| Asbestos-related liabilities                                                  | 1,422                 |            |                   | 1,490      |            |            |            |            |             |             |             |
| Other liabilities                                                             | 6,422                 |            |                   | 6,265      |            |            |            |            |             |             |             |
| Redeemable noncontrolling interest                                            | 7                     |            |                   | 7          |            |            |            |            |             |             |             |
| SHAREOWNERS’ EQUITY                                                           |                       |            |                   |            |            |            |            |            |             |             |             |
| Capital—common stock issued                                                   | 958                   |            |                   | 958        |            |            |            |            |             |             |             |
| —additional paid-in capital                                                   | 9,554                 |            |                   | 9,062      |            |            |            |            |             |             |             |
| Common stock held in treasury, at cost                                        | (38,989)              |            |                   | (38,008)   |            |            |            |            |             |             |             |
| Accumulated other comprehensive income (loss)                                 | (4,404)               |            |                   | (4,135)    |            |            |            |            |             |             |             |
| Retained earnings                                                             | 50,287                |            |                   | 47,979     |            |            |            |            |             |             |             |
| Total Honeywell shareowners’ equity                                           | 17,406                |            |                   | 15,856     |            |            |            |            |             |             |             |
| Noncontrolling interest                                                       | 568                   |            |                   | 578        |            |            |            |            |             |             |             |
| Total shareowners’ equity                                                     | 17,974                |            |                   | 16,434     |            |            |            |            |             |             |             |
| Total liabilities, redeemable noncontrolling interest and shareowners’ equity | $                     | 73,492     |                   |            | $          | 61,525     |            |            |             |             |             |

---

| Column 1                                                                                | Column 2                        | Column 3   | Column 4   | Column 5   | Column 6   | Column 7   | Column 8   | Column 9   | Column 10   | Column 11   | Column 12   |
|:----------------------------------------------------------------------------------------------------------------------|:--------------------------------|:-----------|:-----------|:-----------|:-----------|:-----------|:-----------|:-----------|:------------|:------------|:------------|
|                                                                                |                                 |            |            |            |            |            |            |            |             |             |             |
|                                                                                | Nine Months Ended September 30, |            |            |            |            |            |            |            |             |             |             |
|                                                                                | 2024                            |            | 2023       |            |            |            |            |            |             |             |             |
|                                                                                | (Dollars in millions)           |            |            |            |            |            |            |            |             |             |             |
| Cash flows from operating activities                                                                                |                                 |            |            |            |            |            |            |            |             |             |             |
| Net income                                                                                | $                               | 4,450      |            |            | $          | 4,424      |            |            |             |             |             |
| Less: Net income attributable to noncontrolling interest                                                              | 30                              |            |            | 29         |            |            |            |            |             |             |             |
| Net income attributable to Honeywell                                                                                | 4,420                           |            |            | 4,395      |            |            |            |            |             |             |             |
| Adjustments to reconcile net income attributable to Honeywell to net cash provided by (used for) operating activities |                                 |            |            |            |            |            |            |            |             |             |             |
| Depreciation                                                                                | 500                             |            |            | 493        |            |            |            |            |             |             |             |
| Amortization                                                                                | 457                             |            |            | 382        |            |            |            |            |             |             |             |
| Impairment of assets held for sale                                                                                | 125                             |            |            | —          |            |            |            |            |             |             |             |
| Repositioning and other charges                                                                                | 189                             |            |            | 331        |            |            |            |            |             |             |             |
| Net payments for repositioning and other charges                                                                      | (329)                           |            |            | (323)      |            |            |            |            |             |             |             |
| NARCO Buyout payment                                                                                | —                               |            |            | (1,325)    |            |            |            |            |             |             |             |
| Pension and other postretirement income                                                                               | (443)                           |            |            | (410)      |            |            |            |            |             |             |             |
| Pension and other postretirement benefit payments                                                                     | (25)                            |            |            | (25)       |            |            |            |            |             |             |             |
| Stock compensation expense                                                                                | 153                             |            |            | 148        |            |            |            |            |             |             |             |
| Deferred income taxes                                                                                | (46)                            |            |            | 168        |            |            |            |            |             |             |             |
|                                                                                |                                 |            |            |            |            |            |            |            |             |             |             |
| Other                                                                                | (641)                           |            |            | (554)      |            |            |            |            |             |             |             |
| Changes in assets and liabilities, net of the effects of acquisitions and divestitures                                |                                 |            |            |            |            |            |            |            |             |             |             |
| Accounts receivable                                                                                | (218)                           |            |            | (344)      |            |            |            |            |             |             |             |
| Inventories                                                                                | (233)                           |            |            | (448)      |            |            |            |            |             |             |             |
| Other current assets                                                                                | 195                             |            |            | 141        |            |            |            |            |             |             |             |
| Accounts payable                                                                                | (142)                           |            |            | 96         |            |            |            |            |             |             |             |
| Accrued liabilities                                                                                | (146)                           |            |            | (340)      |            |            |            |            |             |             |             |
| Net cash provided by operating activities                                                                             | 3,816                           |            |            | 2,385      |            |            |            |            |             |             |             |
| Cash flows from investing activities                                                                                |                                 |            |            |            |            |            |            |            |             |             |             |
| Capital expenditures                                                                                | (771)                           |            |            | (675)      |            |            |            |            |             |             |             |
| Proceeds from disposals of property, plant and equipment                                                              | —                               |            |            | 21         |            |            |            |            |             |             |             |
| Increase in investments                                                                                | (698)                           |            |            | (404)      |            |            |            |            |             |             |             |
| Decrease in investments                                                                                | 564                             |            |            | 808        |            |            |            |            |             |             |             |
|                                                                                |                                 |            |            |            |            |            |            |            |             |             |             |
| Receipts (payments) from settlements of derivative contracts                                                          | (250)                           |            |            | 212        |            |            |            |            |             |             |             |
| Cash paid for acquisitions, net of cash acquired                                                                      | (7,047)                         |            |            | (716)      |            |            |            |            |             |             |             |
|                                                                                |                                 |            |            |            |            |            |            |            |             |             |             |
| Net cash used for investing activities                                                                                | (8,202)                         |            |            | (754)      |            |            |            |            |             |             |             |
| Cash flows from financing activities                                                                                |                                 |            |            |            |            |            |            |            |             |             |             |
| Proceeds from issuance of commercial paper and other short-term borrowings                                            | 9,516                           |            |            | 10,727     |            |            |            |            |             |             |             |
| Payments of commercial paper and other short-term borrowings                                                          | (8,477)                         |            |            | (11,484)   |            |            |            |            |             |             |             |
| Proceeds from issuance of common stock                                                                                | 349                             |            |            | 151        |            |            |            |            |             |             |             |
| Proceeds from issuance of long-term debt                                                                              | 10,407                          |            |            | 2,985      |            |            |            |            |             |             |             |
| Payments of long-term debt                                                                                | (1,381)                         |            |            | (1,410)    |            |            |            |            |             |             |             |
| Repurchases of common stock                                                                                | (1,200)                         |            |            | (2,187)    |            |            |            |            |             |             |             |
| Cash dividends paid                                                                                | (2,161)                         |            |            | (2,144)    |            |            |            |            |             |             |             |
| Other                                                                                | 5                               |            |            | (65)       |            |            |            |            |             |             |             |
| Net cash provided by (used for) financing activities                                                                  | 7,058                           |            |            | (3,427)    |            |            |            |            |             |             |             |
| Effect of foreign exchange rate changes on cash and cash equivalents                                                  | 47                              |            |            | (61)       |            |            |            |            |             |             |             |
| Net increase (decrease) in cash and cash equivalents                                                                  | 2,719                           |            |            | (1,857)    |            |            |            |            |             |             |             |
| Cash and cash equivalents at beginning of period                                                                      | 7,925                           |            |            | 9,627      |            |            |            |            |             |             |             |
| Cash and cash equivalents at end of period                                                                            | $                               | 10,644     |            |            | $          | 7,770      |            |            |             |             |             |

---

| Column 1                                                 | Column 2                                        | Column 3   | Column 4                        | Column 5   | Column 6   | Column 7   | Column 8   | Column 9   | Column 10   | Column 11   | Column 12   | Column 13   | Column 14   | Column 15   | Column 16   | Column 17   | Column 18   | Column 19   | Column 20   | Column 21   | Column 22   | Column 23   | Column 24   |
|:---------------------------------------------------------|:------------------------------------------------|:-----------|:--------------------------------|:-----------|:-----------|:-----------|:-----------|:-----------|:------------|:------------|:------------|:------------|:------------|:------------|:------------|:------------|:------------|:------------|:------------|:------------|:------------|:------------|:------------|
|                                                          |                                                 |            |                                 |            |            |            |            |            |             |             |             |             |             |             |             |             |             |             |             |             |             |             |             |
|                                                          | Three Months Ended September 30,                |            | Nine Months Ended September 30, |            |            |            |            |            |             |             |             |             |             |             |             |             |             |             |             |             |             |             |             |
| 2024                                                     |                                                 | 2023       |                                 | 2024       |            | 2023       |            |            |             |             |             |             |             |             |             |             |             |             |             |             |             |             |             |
|                                                          | (Dollars in millions, except per share amounts) |            |                                 |            |            |            |            |            |             |             |             |             |             |             |             |             |             |             |             |             |             |             |             |
| Product sales                                            | $                                               | 6,590      |                                 |            | $          | 6,294      |            |            | $           | 19,330      |             |             | $           | 19,045      |             |             |             |             |             |             |             |             |             |
| Service sales                                            | 3,138                                           |            |                                 | 2,918      |            |            | 9,080      |            |             | 8,177       |             |             |             |             |             |             |             |             |             |             |             |             |             |
| Net sales                                                | 9,728                                           |            |                                 | 9,212      |            |            | 28,410     |            |             | 27,222      |             |             |             |             |             |             |             |             |             |             |             |             |             |
| Costs, expenses and other                                |                                                 |            |                                 |            |            |            |            |            |             |             |             |             |             |             |             |             |             |             |             |             |             |             |             |
| Cost of products sold                                    | 4,166                                           |            |                                 | 4,090      |            |            | 12,448     |            |             | 12,291      |             |             |             |             |             |             |             |             |             |             |             |             |             |
| Cost of services sold                                    | 1,813                                           |            |                                 | 1,580      |            |            | 4,970      |            |             | 4,503       |             |             |             |             |             |             |             |             |             |             |             |             |             |
| Total Cost of products and services sold                 | 5,979                                           |            |                                 | 5,670      |            |            | 17,418     |            |             | 16,794      |             |             |             |             |             |             |             |             |             |             |             |             |             |
| Research and development expenses                        | 368                                             |            |                                 | 364        |            |            | 1,110      |            |             | 1,096       |             |             |             |             |             |             |             |             |             |             |             |             |             |
| Selling, general and administrative expenses             | 1,398                                           |            |                                 | 1,252      |            |            | 4,061      |            |             | 3,831       |             |             |             |             |             |             |             |             |             |             |             |             |             |
| Impairment of assets held for sale                       | 125                                             |            |                                 | —          |            |            | 125        |            |             | —           |             |             |             |             |             |             |             |             |             |             |             |             |             |
| Other (income) expense                                   | (263)                                           |            |                                 | (247)      |            |            | (740)      |            |             | (715)       |             |             |             |             |             |             |             |             |             |             |             |             |             |
| Interest and other financial charges                     | 297                                             |            |                                 | 206        |            |            | 767        |            |             | 563         |             |             |             |             |             |             |             |             |             |             |             |             |             |
| Total costs, expenses and other                          | 7,904                                           |            |                                 | 7,245      |            |            | 22,741     |            |             | 21,569      |             |             |             |             |             |             |             |             |             |             |             |             |             |
| Income before taxes                                      | 1,824                                           |            |                                 | 1,967      |            |            | 5,669      |            |             | 5,653       |             |             |             |             |             |             |             |             |             |             |             |             |             |
| Tax expense                                              | 409                                             |            |                                 | 452        |            |            | 1,219      |            |             | 1,229       |             |             |             |             |             |             |             |             |             |             |             |             |             |
| Net income                                               | 1,415                                           |            |                                 | 1,515      |            |            | 4,450      |            |             | 4,424       |             |             |             |             |             |             |             |             |             |             |             |             |             |
| Less: Net income attributable to noncontrolling interest | 2                                               |            |                                 | 1          |            |            | 30         |            |             | 29          |             |             |             |             |             |             |             |             |             |             |             |             |             |
| Net income attributable to Honeywell                     | $                                               | 1,413      |                                 |            | $          | 1,514      |            |            | $           | 4,420       |             |             | $           | 4,395       |             |             |             |             |             |             |             |             |             |
| Earnings per share of common stock—basic                 | $                                               | 2.17       |                                 |            | $          | 2.29       |            |            | $           | 6.79        |             |             | $           | 6.61        |             |             |             |             |             |             |             |             |             |
| Earnings per share of common stock—assuming dilution     | $                                               | 2.16       |                                 |            | $          | 2.27       |            |            | $           | 6.75        |             |             | $           | 6.56        |             |             |             |             |             |             |             |             |             |

---

English News:
**Honeywell International Inc. Reports Strong Third Quarter Financials** Honeywell International Inc. has reported robust financial results for the third quarter, demonstrating resilience and adaptability amid industry challenges. The multinational conglomerate, known for its diversified technology and manufacturing sectors, announced an impressive increase in free cash flow, which reached $1.7 billion. This figure represents a notable 10% growth year-over-year, showcasing the company's robust financial health despite ongoing difficulties in reducing aerospace inventory and addressing slower payment cycles in high-growth regions. An integral part of Honeywell's success this quarter can be attributed to its Aerospace Technologies segment. The division experienced a substantial 10% organic sales growth, contributing to record backlog levels, which have risen by 10% year-over-year to an unprecedented $34 billion. This indicates strong demand and customer interest in Honeywell's offerings, reinforcing its position as a leader in the aerospace industry. Furthermore, the company's adjusted earnings per share (EPS) increased by 8%, reaching $2.58. This figure exceeds the high end of Honeywell's guidance range and underscores the effectiveness of its strategic initiatives. Notably, the success of the Accelerator operating system and the completion of strategic acquisitions have been pivotal in enhancing operational efficiencies and driving financial performance. Overall, Honeywell's third quarter results highlight the company's ability to navigate complexities in the business landscape while achieving significant milestones. As it continues to leverage its technologies and strategic operations, Honeywell remains well-positioned for sustained growth and success.

Chinese News:
霍尼韦尔连续第七次亮相进博会 以三大发展趋势创新质赢未来 全球高科技企业霍尼韦尔（纳斯达克代码：HON）以“创新质 赢未来”为主题亮相第七届中国国际进口博览会（以下简称“进博会”）。霍尼韦尔展台位于技术装备展区3号馆B4-05展位，聚焦自动化、未来航空和能源转型三大发展趋势，全方位展示公司在智能制造、智慧建筑、航空交通、能源转型等领域的创新技术、产品和应用，致力于与中国合作伙伴共同努力，以一系列成熟技术赋能中国的新质生产力发展。 “作为第一批承诺参加首届进博会的全球企业，今年是霍尼韦尔连续第七年参展。进博会早已成为霍尼韦尔创新技术成果的首发地、推动高层级对话的输出地和构筑开放合作生态圈的策源地。”霍尼韦尔中国总裁余锋表示，“霍尼韦尔今年将展出100余项创新技术、产品和解决方案，展品数量将刷新霍尼韦尔参展以来的纪录，其中包括多项中国首发首秀产品。借助‘进博加速度’，霍尼韦尔将不断开发满足客户需求的创新产品与技术，携手中国合作伙伴赋能新质生产力的发展，共塑智慧低碳未来。” 自动化助力产业数智升级 霍尼韦尔在本届进博会展台上将带来一系列在工业自动化领域和楼宇自动化领域的软件及硬件解决方案。其中，应用于半导体、光伏、工业等领域的Midas S1半导体用气体探测器将进行中国首发，该系列全新产品是霍尼韦尔“东方服务东方”的本土化产品，能在半导体生产流程中检测超过35种主要有毒气体和可燃气体，可大幅助力企业降低气体探测所需的运行成本。在智慧建筑领域，公司以软件平台与硬件设备联动的方式展示霍尼韦尔能碳管控一体化解决方案在多种业态的最佳项目实践，包含医院、酒店、超高层总部、高端制造园区等，同时通过电子沙盘展现霍尼韦尔在区域远程运营上的创新和实践。霍尼韦尔低碳建筑解决方案全新迭代，通过系统协同、机理仿真、算法优化、控制策略等一系列数智技术和创新，赋能楼宇的低碳运维。 未来航空引领行业加速变革 霍尼韦尔的航空航天产品几乎应用于全球所有商用飞机平台，并将继续引领未来航空发展。进博会期间，霍尼韦尔以飞行模拟器的形式，在中国首次公开展示霍尼韦尔开创性的新型地面预警（SURF-A）软件，能够帮助飞行员及时识别跑道危险，避免可能发生的致命事故。霍尼韦尔还将带来今年首款由霍尼韦尔航空航天科技集团中国本土研发团队开发和生产的 HGuide o360C惯性和全球导航卫星系统（GNSS）组合导航板卡，赋能自动驾驶和移动测绘等行业的快速发展。此外，公司以沙盘形式呈现霍尼韦尔可持续航空燃料（SAF）解决方案，展示这项新技术是如何将包括地沟油、藻油、废弃脂肪、非食用植物油、乙醇以及电子甲醇（eMethanol）等在内的各类广泛的可再生原料，制成可持续航空燃料，帮助航司实现低碳飞行。 能源转型驱动可持续发展 作为可持续发展的长期践行者，霍尼韦尔约60%的新产品研发都以改善客户的环保表现和社会效益为出发点。除了展示可持续航空燃料技术，霍尼韦尔将以互动的形式展出在工业及新兴产业领域的多项前沿低碳技术应用，包括可将废塑料变废为宝的霍尼韦尔UpCycle 塑料回收工艺、助力传统石油炼化行业转型升级的霍尼韦尔“未来炼厂”解决方案和智能工厂解决方案等。在新兴的储能领域，霍尼韦尔将展示包括储能电池热管理、储能消防与热失控探测、电池储能系统与先进控制技术等数款产品与解决方案，涵盖新能源汽车、商业和工业运营、电力生产、公共事业等多个领域，为储能安全和可持续高效运营保驾护航。 携手合作伙伴创新质、赢未来 凭借进博会的“溢出效应”，霍尼韦尔充分践行“东方服务东方”的中国市场发展战略，不断加快本土创新步伐，并持续通过进博会这一高水平开放的合作平台拓展合作伙伴关系。在本届进博会上，霍尼韦尔将与航空、交通、石化、建筑、制造业等领域的超过20家企业达成战略合作，共同推动一系列成熟解决方案在中国落地，携手中国合作伙伴共筑科技创新和产业升级之路。 关于霍尼韦尔 霍尼韦尔是一家《财富》全球500强的高科技企业，公司业务围绕自动化、未来航空和能源转型三大发展趋势，以霍尼韦尔加速器运营系统和霍尼韦尔互联平台为依托，在世界范围内为多个行业提供广泛的技术和服务。作为值得信赖的合作伙伴，霍尼韦尔通过航空航天科技集团、智能工业科技集团、智能建筑科技集团、能源与可持续技术集团帮助客户解决棘手和复杂的全球性挑战，提供切实可行的创新解决方案，让世界变得更加智能、安全、可靠和可持续。在中国，霍尼韦尔贯彻“东方服务东方”的战略，以本土创新推动业务发展。目前，霍尼韦尔所有业务集团均已落户中国，上海是霍尼韦尔亚太区总部。欲了解更多公司信息，请访问霍尼韦尔中国网站www.honeywell.com.cn，或关注霍尼韦尔官方微博和官方微信。

Japanese News:
タイトル：ハネウェル、第3四半期決算発表後に株価下落、通期売上高見通しを下方修正 ハネウェル（HON）は、2024年第3四半期（7月～9月）の決算を発表し、1株利益は予想を上回ったものの、売上高は予想を下回りました。既存事業の売上高の伸びも予想に届かず、通期売上高の見通しを下方修正しました。 決算発表後、投資判断を「中立」に引き下げ、目標株価も従来の250ドルから230ドルに下方修正したアナリストも存在します。短期サイクルの回復時期が不透明であり、長期サイクルも業績に一貫性が欠けているとの懸念が示されました。また、長期成長目標である4～7%の上限達成に対する不確実性が高まったとも述べられています。 第3四半期の結果: 調整後EPS: 2.58ドル（予想: 2.51ドル） 売上高: 97.3億ドル（予想: 98.8億ドル） 航空宇宙: 39.1億ドル（予想: 39.7億ドル） 産業: 25.0億ドル（予想: 26.3億ドル） ビルディング: 17.5億ドル（予想: 17.0億ドル） エネルギー・サステナビリティ: 15.6億ドル（予想: 15.8億ドル） 既存事業売上高: +3.0%（予想: +4.9%） フリーキャッシュフロー（FCF）: 17.2億ドル（予想: 16.8億ドル） 通期見通しの修正: 調整後EPS: 10.15～10.25ドル（従来: 10.05～10.25ドル） 売上高: 386～388億ドル（従来: 391～397億ドル） 既存事業売上高: 3～4%増（従来: 5～6%増） FCF: 51～54億ドル（従来: 55～59億ドル） 企業概要: ハネウェルは、エネルギー効率の高い製品とソリューション、航空宇宙製品、産業向けの生産性・センシング・セキュリティ技術など、世界の重要な課題に取り組む技術を提供しています。同社は、物理的な製品とソフトウェアを融合させ、先端材料などを通じて、産業界に貢献しています。

Spanish News:
Honeywell (NASDAQ: HON) anunció sus resultados del tercer trimestre de 2024 el 26 de octubre, con el CEO Vimal Kapur y el CFO Greg Lewis al frente. La compañía superó las expectativas de beneficios por acción (BPA), registrando 2,58 dólares, un aumento del 8% interanual, aunque las ventas no alcanzaron las previsiones del mercado. El crecimiento orgánico se situó en un 3%. El segmento aeroespacial continuó con su sólido rendimiento, con un aumento del 10% en las ventas orgánicas, marcando el noveno trimestre consecutivo de crecimiento de dos dígitos. Puntos clave: BPA ajustado: 2,58 dólares, superando las previsiones del mercado de 2,21 dólares por acción. Ventas: 770,86 millones de dólares, aunque por debajo de las expectativas debido a retrasos en proyectos y problemas en la cadena de suministro. Segmento aeroespacial: 10% de crecimiento en ventas orgánicas. Automatización industrial: Experimentó una disminución del 5% en ventas orgánicas. Adquisiciones y perspectivas: Honeywell completó cuatro adquisiciones en 2024 por un total superior a 9.000 millones de dólares y planea la escisión de su división de materiales avanzados. La empresa espera desplegar 14.000 millones de dólares en capital para finales de 2024 en diversas iniciativas estratégicas. Previsiones revisadas para 2023: Ventas para 2023: Se espera que estén entre 38.600 millones y 38.800 millones de dólares. Crecimiento de ventas orgánicas para 2023: Se ajustó de un crecimiento proyectado del 5%-6% a un 3%-4% debido a los desafíos operativos. Perspectivas para 2024: Honeywell pronostica un crecimiento de bajo doble dígito en Tecnologías Aeroespaciales y un crecimiento de bajo dígito en Automatización de Edificios. Las expectativas para Automatización Industrial se han reducido a una disminución de alto dígito simple. Comentarios de Vimal Kapur, CEO de Honeywell: “Hemos cerrado con un trimestre sólido, superando las expectativas en varios indicadores clave. A pesar de los desafíos operativos, nuestra estrategia de crecimiento sigue siendo fuerte y estamos comprometidos con la optimización de nuestra cartera para generar más valor para los accionistas”, comentó Kapur. "Nuestro enfoque continuo en adquisiciones estratégicas y una cartera de pedidos récord posicionan a Honeywell para un crecimiento continuo." Impacto de la huelga de Boeing: No se espera que la huelga de Boeing afecte los ingresos de Honeywell en el cuarto trimestre, según la empresa. Además, el rendimiento del mercado de posventa comercial mostró un fuerte crecimiento en el mercado internacional. Optimismo para 2025: Honeywell mantiene su optimismo cauteloso para 2025, con perspectivas de crecimiento impulsadas por su sólida cartera de pedidos y la optimización estratégica de su portafolio, incluida la monetización de su inversión en Quantinium, que dependerá de hitos técnicos y la adquisición de clientes.

Greek News:
Η Honeywell προχώρησε στην υποβολή του τριμηνιαίου της οικονομικού δελτίου, καταθέτοντας στις 24 Οκτωβρίου 2024 την έκθεση 10-Q για την περίοδο που έληξε στις 30 Σεπτεμβρίου 2024. Η Επιτροπή Κεφαλαιαγοράς των ΗΠΑ (SEC) αποδέχθηκε την υποβολή, ενισχύοντας τη διαφάνεια και τη συμμόρφωση της εταιρείας με τις κανονιστικές απαιτήσεις. Η έκθεση περιλαμβάνει συνολικά 141 έγγραφα, μεταξύ των οποίων το κύριο έντυπο 10-Q σε μορφή iXBRL, πιστοποιήσεις εκτελεστικών στελεχών, χρηματοοικονομικά παραρτήματα και γραφικά αρχεία που απεικονίζουν τα οικονομικά στοιχεία της περιόδου. Ιδιαίτερη έμφαση δίνεται στην παρουσίαση χρηματοοικονομικών δεδομένων σε μορφή XBRL, με επεκτάσεις ταξινομίας και πλήρες αρχείο παραδείγματος (instance document), διευκολύνοντας τόσο την ανθρώπινη όσο και τη μηχανική ανάγνωση των στοιχείων. Η χρήση αυτών των διαδραστικών τεχνολογιών επιτρέπει την πιο αποτελεσματική επεξεργασία των οικονομικών δεδομένων από επενδυτές, ρυθμιστικούς φορείς και αναλυτές. Η κίνηση αυτή επιβεβαιώνει την προσήλωση της Honeywell στην παροχή έγκαιρης, αναλυτικής και δομημένης πληροφόρησης, όπως απαιτείται από το πλαίσιο χρηματοοικονομικής λογοδοσίας των εισηγμένων εταιρειών.

Question:
What are the company's capital expenditures and their strategic significance from the news? Please quote all the relevant financial information from the financial statements supporting the finding(s), if any.

Answer:

Question: What are the company's capital expenditures and their strategic significance from the news? Please quote all the relevant financial information from the financial statements supporting the finding(s), if any.


Question:
You are tasked with answering the user's question using the provided context, which includes financial statements (Income Statements, Balance Sheets, and Cash Flow Statements) and financial news articles in multiple languages (English, Chinese, Japanese, Spanish, and Greek). Please provide a detailed and well-supported answer based on the information available. Limit your response to 100 words or fewer. If you cannot answer the question or if no relevant evidence is found, write “None”.

Answer Format:
Answer: {Answer by summarizing the financial news.}
Financial Statements Evidence: {Verify your answer using quote(s) from the financial statements (include original amounts if relevant). Write “None” if no statement evidence is available.}
Context:
Financial Statements:
| Column 1                                                                      | Column 2              | Column 3   | Column 4   | Column 5   | Column 6   | Column 7   | Column 8   | Column 9   | Column 10   | Column 11   | Column 12   |
|:------------------------------------------------------------------------------|:----------------------|:-----------|:-----------|:-----------|:-----------|:-----------|:-----------|:-----------|:------------|:------------|:------------|
|                                                                               |                       |            |            |            |            |            |            |            |             |             |             |
|                                                                               | December 31,          |            |            |            |            |            |            |            |             |             |             |
| 2024                                                                          |                       | 2023       |            |            |            |            |            |            |             |             |             |
|                                                                               | (Dollars in millions) |            |            |            |            |            |            |            |             |             |             |
| ASSETS                                                                        |                       |            |            |            |            |            |            |            |             |             |             |
| Current assets                                                                |                       |            |            |            |            |            |            |            |             |             |             |
| Cash and cash equivalents                                                     | $                     | 10,567     |            |            | $          | 7,925      |            |            |             |             |             |
| Short-term investments                                                        | 386                   |            |            | 170        |            |            |            |            |             |             |             |
| Accounts receivable, less allowances of $314and $323, respectively            | 7,819                 |            |            | 7,530      |            |            |            |            |             |             |             |
| Inventories                                                                   | 6,442                 |            |            | 6,178      |            |            |            |            |             |             |             |
| Assets held for sale                                                          | 1,365                 |            |            | —          |            |            |            |            |             |             |             |
| Other current assets                                                          | 1,329                 |            |            | 1,699      |            |            |            |            |             |             |             |
| Total current assets                                                          | 27,908                |            |            | 23,502     |            |            |            |            |             |             |             |
| Investments and long-term receivables                                         | 1,394                 |            |            | 939        |            |            |            |            |             |             |             |
| Property, plant and equipment—net                                             | 6,194                 |            |            | 5,660      |            |            |            |            |             |             |             |
| Goodwill                                                                      | 21,825                |            |            | 18,049     |            |            |            |            |             |             |             |
| Other intangible assets—net                                                   | 6,656                 |            |            | 3,231      |            |            |            |            |             |             |             |
| Insurance recoveries for asbestos-related liabilities                         | 171                   |            |            | 170        |            |            |            |            |             |             |             |
| Deferred income taxes                                                         | 238                   |            |            | 392        |            |            |            |            |             |             |             |
| Other assets                                                                  | 10,810                |            |            | 9,582      |            |            |            |            |             |             |             |
| Total assets                                                                  | $                     | 75,196     |            |            | $          | 61,525     |            |            |             |             |             |
| LIABILITIES                                                                   |                       |            |            |            |            |            |            |            |             |             |             |
| Current liabilities                                                           |                       |            |            |            |            |            |            |            |             |             |             |
| Accounts payable                                                              | $                     | 6,880      |            |            | $          | 6,849      |            |            |             |             |             |
| Commercial paper and other short-term borrowings                              | 4,273                 |            |            | 2,085      |            |            |            |            |             |             |             |
| Current maturities of long-term debt                                          | 1,347                 |            |            | 1,796      |            |            |            |            |             |             |             |
| Accrued liabilities                                                           | 8,348                 |            |            | 7,809      |            |            |            |            |             |             |             |
| Liabilities held for sale                                                     | 408                   |            |            | —          |            |            |            |            |             |             |             |
| Total current liabilities                                                     | 21,256                |            |            | 18,539     |            |            |            |            |             |             |             |
| Long-term debt                                                                | 25,479                |            |            | 16,562     |            |            |            |            |             |             |             |
| Deferred income taxes                                                         | 1,787                 |            |            | 2,094      |            |            |            |            |             |             |             |
| Postretirement benefit obligations other than pensions                        | 112                   |            |            | 134        |            |            |            |            |             |             |             |
| Asbestos-related liabilities                                                  | 1,325                 |            |            | 1,490      |            |            |            |            |             |             |             |
| Other liabilities                                                             | 6,076                 |            |            | 6,265      |            |            |            |            |             |             |             |
| Redeemable noncontrolling interest                                            | 7                     |            |            | 7          |            |            |            |            |             |             |             |
| SHAREOWNERS’ EQUITY                                                           |                       |            |            |            |            |            |            |            |             |             |             |
| Capital—common stock issued                                                   | 958                   |            |            | 958        |            |            |            |            |             |             |             |
| —additional paid-in capital                                                   | 9,695                 |            |            | 9,062      |            |            |            |            |             |             |             |
| Common stock held in treasury, at cost                                        | (39,378)              |            |            | (38,008)   |            |            |            |            |             |             |             |
| Accumulated other comprehensive loss                                          | (3,491)               |            |            | (4,135)    |            |            |            |            |             |             |             |
| Retained earnings                                                             | 50,835                |            |            | 47,979     |            |            |            |            |             |             |             |
| Total Honeywell shareowners’ equity                                           | 18,619                |            |            | 15,856     |            |            |            |            |             |             |             |
| Noncontrolling interest                                                       | 535                   |            |            | 578        |            |            |            |            |             |             |             |
| Total shareowners’ equity                                                     | 19,154                |            |            | 16,434     |            |            |            |            |             |             |             |
| Total liabilities, redeemable noncontrolling interest and shareowners’ equity | $                     | 75,196     |            |            | $          | 61,525     |            |            |             |             |             |

---

CONSOLIDATED STATEMENT OF CASH FLOWS

|     |     |     |     |     |     |     |     |     |     |     |     |     |     |     |     |     |     |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
|     |     |     |     |     |     |     |     |     |     |     |     |     |     |     |     |     |     |
|     |     |     | Years Ended December 31, |     |     |     |     |     |     |     |     |     |     |     |     |     |     |
| 2024 |     |     |     |     |     | 2023 |     |     |     |     |     | 2022 |     |     |
|     |     |     | (Dollars in millions) |     |     |     |     |     |     |     |     |     |     |     |     |     |     |
| Cash flows from operating activities |     |     |     |     |     |     |     |     |     |     |     |     |     |     |     |     |     |
| Net income |     |     | $   | 5,740 |     |     |     |     | $   | 5,672 |     |     |     |     | $   | 4,967 |     |
| Less: Net income attributable to noncontrolling interest |     |     | 35  |     |     |     |     |     | 14  |     |     |     |     |     | 1   |     |     |
| Net income attributable to Honeywell |     |     | 5,705 |     |     |     |     |     | 5,658 |     |     |     |     |     | 4,966 |     |     |
| Adjustments to reconcile net income attributable to Honeywell to net cash provided by operating activities |     |     |     |     |     |     |     |     |     |     |     |     |     |     |     |     |     |
| Depreciation |     |     | 671 |     |     |     |     |     | 659 |     |     |     |     |     | 657 |     |     |
| Amortization |     |     | 663 |     |     |     |     |     | 517 |     |     |     |     |     | 547 |     |     |
| Loss (gain) on sale of non-strategic businesses and assets |     |     | 1   |     |     |     |     |     | (5) |     |     |     |     |     | (22) |     |     |
| Impairment of assets held for sale |     |     | 219 |     |     |     |     |     | —   |     |     |     |     |     | —   |     |     |
| Repositioning and other charges |     |     | 244 |     |     |     |     |     | 860 |     |     |     |     |     | 1,266 |     |     |
| Net payments for repositioning and other charges |     |     | (479) |     |     |     |     |     | (459) |     |     |     |     |     | (512) |     |     |
| NARCO Buyout payment |     |     | —   |     |     |     |     |     | (1,325) |     |     |     |     |     | —   |     |     |
| Pension and other postretirement income |     |     | (476) |     |     |     |     |     | (406) |     |     |     |     |     | (510) |     |     |
| Pension and other postretirement benefit payments |     |     | (32) |     |     |     |     |     | (38) |     |     |     |     |     | (23) |     |     |
| Stock compensation expense |     |     | 194 |     |     |     |     |     | 202 |     |     |     |     |     | 188 |     |     |
| Deferred income taxes |     |     | (233) |     |     |     |     |     | 153 |     |     |     |     |     | (180) |     |     |
|     |     |     |     |     |     |     |     |     |     |     |     |     |     |     |     |     |     |
| Other |     |     | (617) |     |     |     |     |     | (837) |     |     |     |     |     | (358) |     |     |
| Changes in assets and liabilities, net of the effects of acquisitions and divestitures |     |     |     |     |     |     |     |     |     |     |     |     |     |     |     |     |     |
| Accounts receivable |     |     | (96) |     |     |     |     |     | (42) |     |     |     |     |     | (739) |     |     |
| Inventories |     |     | (304) |     |     |     |     |     | (626) |     |     |     |     |     | (440) |     |     |
| Other current assets |     |     | 371 |     |     |     |     |     | 17  |     |     |     |     |     | 232 |     |     |
| Accounts payable |     |     | 95  |     |     |     |     |     | 518 |     |     |     |     |     | (155) |     |     |
| Accrued liabilities |     |     | 171 |     |     |     |     |     | 494 |     |     |     |     |     | 357 |     |     |
| Net cash provided by operating activities |     |     | 6,097 |     |     |     |     |     | 5,340 |     |     |     |     |     | 5,274 |     |     |
| Cash flows from investing activities |     |     |     |     |     |     |     |     |     |     |     |     |     |     |     |     |     |
| Capital expenditures |     |     | (1,164) |     |     |     |     |     | (1,039) |     |     |     |     |     | (766) |     |     |
| Proceeds from disposals of property, plant and equipment |     |     | —   |     |     |     |     |     | 43  |     |     |     |     |     | 29  |     |     |
| Increase in investments |     |     | (1,077) |     |     |     |     |     | (560) |     |     |     |     |     | (1,211) |     |     |
| Decrease in investments |     |     | 870 |     |     |     |     |     | 971 |     |     |     |     |     | 1,255 |     |     |
| Receipts from Garrett Motion Inc. |     |     | —   |     |     |     |     |     | —   |     |     |     |     |     | 409 |     |     |
| Receipts from settlements of derivative contracts |     |     | 94  |     |     |     |     |     | 6   |     |     |     |     |     | 369 |     |     |
| Cash paid for acquisitions, net of cash acquired |     |     | (8,880) |     |     |     |     |     | (718) |     |     |     |     |     | (178) |     |     |
| Proceeds from sales of businesses, net of fees paid |     |     | —   |     |     |     |     |     | 4   |     |     |     |     |     | —   |     |     |
| Net cash used for investing activities |     |     | (10,157) |     |     |     |     |     | (1,293) |     |     |     |     |     | (93) |     |     |
| Cash flows from financing activities |     |     |     |     |     |     |     |     |     |     |     |     |     |     |     |     |     |
| Proceeds from issuance of commercial paper and other short-term borrowings |     |     | 13,838 |     |     |     |     |     | 12,991 |     |     |     |     |     | 7,661 |     |     |
| Payments of commercial paper and other short-term borrowings |     |     | (11,578) |     |     |     |     |     | (13,663) |     |     |     |     |     | (8,447) |     |     |
| Proceeds from issuance of common stock |     |     | 537 |     |     |     |     |     | 196 |     |     |     |     |     | 320 |     |     |
| Proceeds from issuance of long-term debt |     |     | 10,408 |     |     |     |     |     | 2,986 |     |     |     |     |     | 2,953 |     |     |
| Payments of long-term debt |     |     | (1,812) |     |     |     |     |     | (1,731) |     |     |     |     |     | (1,850) |     |     |
| Repurchases of common stock |     |     | (1,655) |     |     |     |     |     | (3,715) |     |     |     |     |     | (4,200) |     |     |
| Cash dividends paid |     |     | (2,902) |     |     |     |     |     | (2,855) |     |     |     |     |     | (2,719) |     |     |
|     |     |     |     |     |     |     |     |     |     |     |     |     |     |     |     |     |     |
|     |     |     |     |     |     |     |     |     |     |     |     |     |     |     |     |     |     |
| Other |     |     | 3   |     |     |     |     |     | 28  |     |     |     |     |     | (48) |     |     |
| Net cash provided by (used for) financing activities |     |     | 6,839 |     |     |     |     |     | (5,763) |     |     |     |     |     | (6,330) |     |     |
| Effect of foreign exchange rate changes on cash and cash equivalents |     |     | (137) |     |     |     |     |     | 14  |     |     |     |     |     | (183) |     |     |
| Net increase (decrease) in cash and cash equivalents |     |     | 2,642 |     |     |     |     |     | (1,702) |     |     |     |     |     | (1,332) |     |     |
| Cash and cash equivalents at beginning of period |     |     | 7,925 |     |     |     |     |     | 9,627 |     |     |     |     |     | 10,959 |     |     |
| Cash and cash equivalents at end of period |     |     | $   | 10,567 |     |     |     |     | $   | 7,925 |     |     |     |     | $   | 9,627 |     |

---

| Column 1                                                 | Column 2                                       | Column 3   | Column 4   | Column 5   | Column 6   | Column 7   | Column 8   | Column 9   | Column 10   | Column 11   | Column 12   | Column 13   | Column 14   | Column 15   | Column 16   | Column 17   | Column 18   |
|:---------------------------------------------------------|:-----------------------------------------------|:-----------|:-----------|:-----------|:-----------|:-----------|:-----------|:-----------|:------------|:------------|:------------|:------------|:------------|:------------|:------------|:------------|:------------|
|                                                          |                                                |            |            |            |            |            |            |            |             |             |             |             |             |             |             |             |             |
|                                                          | Years Ended December 31,                       |            |            |            |            |            |            |            |             |             |             |             |             |             |             |             |             |
| 2024                                                     |                                                | 2023       |            | 2022       |            |            |            |            |             |             |             |             |             |             |             |             |             |
|                                                          | (Dollars in millions,except per share amounts) |            |            |            |            |            |            |            |             |             |             |             |             |             |             |             |             |
| Product sales                                            | $                                              | 26,279     |            |            | $          | 25,773     |            |            | $           | 25,960      |             |             |             |             |             |             |             |
| Service sales                                            | 12,219                                         |            |            | 10,889     |            |            | 9,506      |            |             |             |             |             |             |             |             |             |             |
| Net sales                                                | 38,498                                         |            |            | 36,662     |            |            | 35,466     |            |             |             |             |             |             |             |             |             |             |
| Costs, expenses and other                                |                                                |            |            |            |            |            |            |            |             |             |             |             |             |             |             |             |             |
| Cost of products sold                                    | 17,227                                         |            |            | 16,977     |            |            | 16,955     |            |             |             |             |             |             |             |             |             |             |
| Cost of services sold                                    | 6,609                                          |            |            | 6,018      |            |            | 5,392      |            |             |             |             |             |             |             |             |             |             |
| Total Cost of products and services sold                 | 23,836                                         |            |            | 22,995     |            |            | 22,347     |            |             |             |             |             |             |             |             |             |             |
| Research and development expenses                        | 1,536                                          |            |            | 1,456      |            |            | 1,478      |            |             |             |             |             |             |             |             |             |             |
| Selling, general and administrative expenses             | 5,466                                          |            |            | 5,127      |            |            | 5,214      |            |             |             |             |             |             |             |             |             |             |
| Impairment of assets held for sale                       | 219                                            |            |            | —          |            |            | —          |            |             |             |             |             |             |             |             |             |             |
| Other (income) expense                                   | (830)                                          |            |            | (840)      |            |            | (366)      |            |             |             |             |             |             |             |             |             |             |
| Interest and other financial charges                     | 1,058                                          |            |            | 765        |            |            | 414        |            |             |             |             |             |             |             |             |             |             |
| Total costs, expenses and other                          | 31,285                                         |            |            | 29,503     |            |            | 29,087     |            |             |             |             |             |             |             |             |             |             |
| Income before taxes                                      | 7,213                                          |            |            | 7,159      |            |            | 6,379      |            |             |             |             |             |             |             |             |             |             |
| Tax expense                                              | 1,473                                          |            |            | 1,487      |            |            | 1,412      |            |             |             |             |             |             |             |             |             |             |
| Net income                                               | 5,740                                          |            |            | 5,672      |            |            | 4,967      |            |             |             |             |             |             |             |             |             |             |
| Less: Net income attributable to noncontrolling interest | 35                                             |            |            | 14         |            |            | 1          |            |             |             |             |             |             |             |             |             |             |
| Net income attributable to Honeywell                     | $                                              | 5,705      |            |            | $          | 5,658      |            |            | $           | 4,966       |             |             |             |             |             |             |             |
| Earnings per share of common stock—basic                 | $                                              | 8.76       |            |            | $          | 8.53       |            |            | $           | 7.33        |             |             |             |             |             |             |             |
| Earnings per share of common stock—assuming dilution     | $                                              | 8.71       |            |            | $          | 8.47       |            |            | $           | 7.27        |             |             |             |             |             |             |             |

---

English News:
**Honeywell Reports Annual Financial Performance with Enhanced Earnings Amid Strategic Investments** Honeywell International Inc. has unveiled its financial results for the fiscal year ending December 31, 2024, demonstrating robust growth despite challenges in some segments. The company reported net sales of $38.5 billion, marking a 5% increase over the prior year. This growth was mainly fueled by increased sales volumes, strategic pricing adjustments, and significant contributions from recent acquisitions. However, the Industrial Automation segment experienced a 7% decline in sales. The company's net income attributable to Honeywell reached $5.7 billion, translating to earnings per share (EPS) of $8.71, an improvement from the previous year's EPS of $8.47. The enhanced earnings were supported by a gross margin increase to 38.1%, up from 37.3% in the previous year. On the investment front, Honeywell's cash flow statement reveals substantial activity, with cash paid for acquisitions totaling $8.88 billion. This significant outlay was a primary driver for the net cash outflow from investing activities, which amounted to $10.157 billion for the year. This strategic investment underscores Honeywell's commitment to enhancing its growth trajectory through acquisitions and partnerships. Overall, Honeywell's financial performance highlights a strong year marked by strategic investments and improved profitability, despite sector-specific challenges. The company's focus on growth through acquisitions and efficiency improvements appears to be yielding positive results.

Chinese News:
霍尼韦尔披露分拆计划：拟成立三家独立上市公司 美国当地时间2月6日，霍尼韦尔（HON.US）通过重大业务调整计划，其董事会已完成由董事长兼首席执行官柯伟茂（Vimal Kapur）一年前启动的全面业务组合评估，并计划分拆自动化和航空航天业务。 《中国经营报》记者从霍尼韦尔方面获悉，此次分拆，加上之前已宣布剥离的高性能材料业务，霍尼韦尔将成立三家独立上市企业。分拆计划将于2026年下半年完成。 柯伟茂（Vimal Kapur）表示，此举将释放巨大价值，为每家公司量身制订增长战略。同日，霍尼韦尔还公布了2024年第四季度和全年业绩：全年实现销售额384.98亿美元，同比增长5%，并预计2025年的销售额为396亿至406亿美元，内生式销售额同比增长2%至5%。 分拆上市 2024年10月，霍尼韦尔宣布计划将其高性能材料业务分拆为一家独立的美国上市公司，该业务预计于2025年年底或2026年年初完成。 加上此次分拆的自动化和航空航天业务，霍尼韦尔将成立三家独立上市企业。 对于此次的分拆细节，霍尼韦尔方面表示，自动化和航空航天业务的分拆计划预计以对霍尼韦尔股东免税的方式实现，并计划于2026年下半年完成，但须符合某些惯例条件。 上述分拆计划发布后，霍尼韦尔的股价在2月7日下跌2.05%，收于205.520美元。 霍尼韦尔方面表示，2025年，其将计划投入至少250亿美元用于高回报资本支出、股息、机会性股票购买和增值收购，在分拆过程中继续其业务组合的转型，以增强每项业务的价值主张。 记者了解到，分拆完成后，霍尼韦尔成立的三家独立上市公司包括霍尼韦尔自动化、霍尼韦尔航空航天、霍尼韦尔高性能材料。 其中，霍尼韦尔自动化将聚焦能源安全、可持续到数字化、人工智能领域，2024年营收约为180亿美元；霍尼韦尔航空航天目标成为最大的独立上市的航空航天供应商之一，2024年营收超150亿美元；霍尼韦尔高性能材料专注于可持续发展的特种化学品和材料业务，专注于氟产品、电子材料、工业级纤维和医疗包装解决方案领域，2024年营收近40亿美元。 2024年销售额超380亿美元 在宣布上述分拆计划的同日，霍尼韦尔还公布了2024年第四季度和全年业绩。 财报数据显示，霍尼韦尔2024年全年实现销售额384.98亿美元，同比增长5%。 此外，霍尼韦尔2024年全年每股收益为8.71美元，同比增长3%。调整后每股收益增长4%，至9.89美元。 霍尼韦尔方面提到，尽管宏观经济仍面临挑战，但公司的未交货订单增长了11%，达到创纪录的353亿美元。 同时，霍尼韦尔还公布了2025年业绩展望。霍尼韦尔预计2025年的销售额为396亿至406亿美元，内生式销售额同比增长2%至5%。部门利润率预计将在23.2%至23.6%，部门利润率增长60至100个基点。调整后每股收益预计为10.1至10.5美元之间，同比增长2%至6%。运营现金流预计为67亿至71亿美元，自由现金流为54亿至58亿美元。

Japanese News:
ハネウェル・インターナショナル（Honeywell International Inc.）は2024年第4四半期の決算を発表し、収益とEPS（調整後1株当たり利益）が予想を上回ったものの、自動化と航空宇宙部門の事業分割計画を発表したことで株価が下落しました。 決算結果： 売上高: 100.9億ドル、前年同期比7％増（有機的には2％増）、市場予想の98.3億ドルを上回った。 営業利益率: 17.3％、前年同期比50ベーシスポイント（BPS）増加。 セグメント利益率: 20.9％、前年同期比350ベーシスポイント減少。 調整後EPS: 2.47ドル、前年同期比8％増、予想の2.32ドルを上回った。 営業キャッシュフロー: 22.8億ドル、フリーキャッシュフロー: 18.9億ドル。 現金および流動資産: 約109億ドル（2024年12月31日時点）。 部門別売上： 航空宇宙技術: 39.9億ドル、前年同期比9％増。 産業用自動化: 25.7億ドル、前年同期比1％減。 建物用途自動化: 18.0億ドル、前年同期比20％増。 エネルギー・持続可能ソリューション: 17.3億ドル、前年同期比4％増。 2025会計年度見通し： 売上高予想: 39.6億ドル〜40.6億ドル、オーガニック売上高成長率は2％〜5％の範囲。 調整後EPS予想: 10.10ドル〜10.50ドル、前年同期比で7〜10％増加。 フリーキャッシュフロー予想: 54億ドル〜58億ドル。 営業キャッシュフロー予想: 67億ドル〜71億ドル。 事業分割計画： ハネウェルは、自社の取締役会が自動化と航空宇宙の事業部門を分割する計画を進めていることを明らかにしました。この分割により、Honeywell Automation、Honeywell Aerospace、Advanced Materialsの3つの公開企業が設立されます。この分割は2026年下半期に完了予定で、株主にとっては非課税の構造となります。 コメント： Vimal Kapur最高経営責任者（CEO）は、「2024年、私たちはHoneywellのポートフォリオを最適化し、重要な戦略的買収を通じて、我々の成長を促進しています。これからも高リターンの資本支出、配当、株買い取り、および買収を通じて、引き続き価値を創造していきます」と述べました。

Spanish News:
Honeywell ha anunciado su decisión de dividirse en tres compañías cotizadas de manera independiente, lo que incluirá la separación de sus negocios de automatización, tecnología aeroespacial y materiales avanzados. Este movimiento responde a una estrategia de crecimiento diferenciada para cada área y se espera que la escisión de Honeywell Automation y Honeywell Aerospace se complete de manera libre de impuestos para los accionistas en la segunda mitad de 2026. La separación del negocio de materiales avanzados está prevista para finales de 2025 o principios de 2026. Estrategia de crecimiento y perspectivas: Honeywell ha confirmado que las tres empresas independientes estarán adecuadamente capitalizadas y contarán con la flexibilidad financiera para aprovechar futuras oportunidades de crecimiento. La compañía aseguró que las empresas segregadas mantendrán una escala global y destacaron que Honeywell Automation alcanzó ingresos de 18.000 millones de dólares en 2024, mientras que Honeywell Aerospace facturó 15.000 millones de dólares. La división de materiales avanzados registró una cifra de negocio de casi 4.000 millones de dólares. La decisión de dividir la empresa llega tras la presión del inversor activista Elliott Investment Management, que en noviembre reveló una posición de más de 5.000 millones de dólares en Honeywell y pidió una escisión debido al bajo rendimiento de las acciones, en parte debido a la estructura de conglomerado de la empresa. Resultados anuales de 2024: En 2024, Honeywell reportó un beneficio neto atribuido de 5.705 millones de dólares, un aumento del 0,8% en comparación con el año anterior. Las ventas netas alcanzaron los 38.498 millones de dólares, lo que representa un crecimiento del 5%, impulsado por un avance del 2% en la comercialización de productos y un aumento del 12,2% en la venta de servicios. En el cuarto trimestre de 2024, Honeywell registró un beneficio neto atribuido de 1.285 millones de dólares, un 1,7% más que en el mismo período de 2023, mientras que las ventas netas alcanzaron los 10.088 millones de dólares, un incremento del 6,9%. Perspectivas para 2025: Honeywell ha actualizado sus expectativas para 2025, proyectando una cifra de negocio neta de entre 39.600 y 40.600 millones de dólares, lo que implica un crecimiento orgánico de entre el 2% y el 5% respecto a 2024. Además, espera un beneficio por acción ajustado de entre 10,10 y 10,50 dólares, lo que representaría una mejora anual de entre el 2% y el 6%. Declaraciones de Vimal Kapur: Vimal Kapur, presidente y CEO de Honeywell, comentó: "Hemos cerrado un año exitoso, superando nuestras previsiones de ventas y ganancias ajustadas por acción del cuarto trimestre, a pesar de un entorno operativo dinámico. Estoy convencido de que nuestra estrategia de optimización de la cartera y nuestra sólida base nos permitirán crear aún más valor para nuestros accionistas, clientes y empleados en 2025".

Greek News:
Η Honeywell υπέβαλε, στις 14 Φεβρουαρίου 2025, την ετήσια έκθεση 10-K για το οικονομικό έτος που έληξε στις 31 Δεκεμβρίου 2024, σύμφωνα με τις απαιτήσεις αναφοράς της Επιτροπής Κεφαλαιαγοράς των ΗΠΑ (SEC), βάσει των Τμημάτων 13 και 15(d) του Νόμου περί Χρηματιστηριακών Συναλλαγών. Η υποβολή της εταιρείας περιλάμβανε συνολικά 216 ξεχωριστά έγγραφα. Ανάμεσά τους συγκαταλέγονται η κύρια Φόρμα 10-K σε μορφή iXBRL, πολυάριθμα παραρτήματα, συμφωνίες με στελέχη, πιστοποιήσεις, καθώς και περισσότερα από 50 υποστηρικτικά γραφικά αρχεία. Όλα τα στοιχεία εντάσσονται στο πλαίσιο της συμμόρφωσης με τις απαιτήσεις διαφάνειας και πληροφόρησης προς τους επενδυτές. Η έκθεση καλύπτει την οικονομική και επιχειρησιακή απόδοση της Honeywell για τη διάρκεια του 2024, περιλαμβάνοντας αναλυτικά οικονομικά δεδομένα με σήμανση XBRL, τα οποία συνδέονται με την καταχώριση της εταιρείας στην SEC υπό τον Κωδικό Κεντρικού Αναγνωριστικού (CIK) 0000773840.

Question:
Please list the top three focuses on revenue from news? Please quote all the relevant financial information from the financial statements supporting the finding(s), if any.

Answer:

Question: Please list the top three focuses on revenue from news? Please quote all the relevant financial information from the financial statements supporting the finding(s), if any.